| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |